The corporate purpose of Epidisease is research, technological development and marketing of products and services based on epigenetic principles, in the field of molecular diagnostics focused on medical and health activities. Among the services performed by Epidisease are: DNA methylation analysis; the analysis of post-translational modifications in histones; the study of expression of microRNAs; the detection of circulating microRNAs in biological fluids; the characterisation of new epigenetic biomarkers and the “in vitro” study of the epigenetic activity of bioactive molecules.
Its objective is to transfer the most innovative knowledge and existing technologies to the market, providing a high added value, with the mission of improving the health and well-being of people, not only in the short term, but also thinking about their offspring.
The information contained in this business data sheep has been provided by the company and the University of Valencia Science Park Foundation (FPCUV) is not responsible for its content.
Download Impulse to Business Development Programme (PIDE)'s file
INNOVATIVE ASPECTS
COMPETITIVE ADVANTAGES